TriGuard Embolic Protection Device in percutaneous cardiac interventions with intracavitary cardiac thrombosis: A case series
Related Experiment Video
Updated: Jul 29, 2025

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Lorenzo Marcon1, Rita Sicuso1, Stefano Galli2
1Cardiac Arrhythmia Research Centre, Centro Cardiologico Monzino, IRCCS, Milan, Italy.
Insights
Cerebral embolic protection devices are rarely used in electrophysiology. This case series shows the TriGuard 3 device successfully protected patients during left atrial appendage closure and ventricular tachycardia ablation.
Area of Science:
- Cardiology
- Neurology
- Medical Devices
Background:
- Cerebral embolic protection devices are underutilized in electrophysiological procedures.
- Intracardiac thrombosis poses a risk during left atrial appendage (LAA) closure and ventricular tachycardia (VT) ablation.
Abstract:
Embolic cerebral protection devices are not routinely used in clinical practice during electrophysiological interventions. We report a case series of patients with intracardiac thrombosis undergoing a percutaneous left atrial appendage (LAA) closure and a ventricular tachycardia (VT) catheter ablation supported by TriGuard 3 Cerebral Embolic Protection Device.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Venous Thrombosis I: Introduction

